FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Nov 21, 2016
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on November 21, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ee943d3f-a354-4a97-8609-5717fd6b933b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 998099
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Merck Sharp & Dohme LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2026 | Not classified | Atlanta District Office | |
| June 12, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 16, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| October 30, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 24, 2014 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1318208 - 2026-05-20
- FDA Inspection 1230849 - 2024-06-12
- FDA Inspection 1140222 - 2021-04-16
- FDA Inspection 1070336 - 2018-10-30
- FDA Inspection 903682 - 2014-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.